103 related articles for article (PubMed ID: 22014045)
1. Increased Toll-like receptor 9 expression indicates adverse prognosis in oesophageal adenocarcinoma.
Kauppila JH; Takala H; Selander KS; Lehenkari PP; Saarnio J; Karttunen TJ
Histopathology; 2011 Oct; 59(4):643-9. PubMed ID: 22014045
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of Toll-like receptor-9 has close relation with tumour cell proliferation in oral squamous cell carcinoma.
Min R; Zun Z; Siyi L; Wenjun Y; Lizheng W; Chenping Z
Arch Oral Biol; 2011 Sep; 56(9):877-84. PubMed ID: 21333270
[TBL] [Abstract][Full Text] [Related]
3. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
[TBL] [Abstract][Full Text] [Related]
4. E2F-1 overexpression correlates with decreased proliferation and better prognosis in adenocarcinomas of Barrett oesophagus.
Evangelou K; Kotsinas A; Mariolis-Sapsakos T; Giannopoulos A; Tsantoulis PK; Constantinides C; Troupis TG; Salmas M; Kyroudis A; Kittas C; Gorgoulis VG
J Clin Pathol; 2008 May; 61(5):601-5. PubMed ID: 17908803
[TBL] [Abstract][Full Text] [Related]
5. Cytoplasmic beta-catenin accumulation is a good prognostic marker in upper and lower gastrointestinal adenocarcinomas.
Norwood MG; Bailey N; Nanji M; Gillies RS; Nicholson A; Ubhi S; Darnton JJ; Steyn RS; Womack C; Hughes A; Hemingway D; Harrison R; Waters R; Jankowski JA
Histopathology; 2010 Jul; 57(1):101-11. PubMed ID: 20572881
[TBL] [Abstract][Full Text] [Related]
6. Alpha- and beta-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer: an immunohistochemical study.
Powe DG; Voss MJ; Habashy HO; Zänker KS; Green AR; Ellis IO; Entschladen F
Breast Cancer Res Treat; 2011 Nov; 130(2):457-63. PubMed ID: 21298476
[TBL] [Abstract][Full Text] [Related]
7. Increased E2F-1 expression via tumour cell proliferation and decreased apoptosis are correlated with adverse prognosis in patients with squamous cell carcinoma of the oesophagus.
Yamazaki K; Hasegawa M; Ohoka I; Hanami K; Asoh A; Nagao T; Sugano I; Ishida Y
J Clin Pathol; 2005 Sep; 58(9):904-10. PubMed ID: 16126868
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 9 is a novel biomarker for esophageal squamous cell dysplasia and squamous cell carcinoma progression.
Takala H; Kauppila JH; Soini Y; Selander KS; Vuopala KS; Lehenkari PP; Saarnio J; Karttunen TJ
J Innate Immun; 2011; 3(6):631-8. PubMed ID: 21876325
[TBL] [Abstract][Full Text] [Related]
9. High expression of Y-box-binding protein-1 is associated with poor survival in resectable esophageal squamous cell carcinoma.
Li Y; Wen ZS; Yang HX; Luo RZ; Zhang Y; Zhang MF; Wang X; Jia WH
Ann Surg Oncol; 2011 Nov; 18(12):3370-6. PubMed ID: 21630125
[TBL] [Abstract][Full Text] [Related]
10. Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma.
Gockel I; Schimanski CC; Heinrich C; Wehler T; Frerichs K; Drescher D; von Langsdorff C; Domeyer M; Biesterfeld S; Galle PR; Junginger T; Moehler M
BMC Cancer; 2006 Dec; 6():290. PubMed ID: 17176471
[TBL] [Abstract][Full Text] [Related]
11. Over-expression of phosphorylated mammalian target of rapamycin is associated with poor survival in oesophageal adenocarcinoma: a tissue microarray study.
Prins MJ; Verhage RJ; Ruurda JP; ten Kate FJ; van Hillegersberg R
J Clin Pathol; 2013 Mar; 66(3):224-8. PubMed ID: 23162107
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
[TBL] [Abstract][Full Text] [Related]
13. Reduced expression of the cadherin-catenin complex in oesophageal adenocarcinoma correlates with poor prognosis.
Krishnadath KK; Tilanus HW; van Blankenstein M; Hop WC; Kremers ED; Dinjens WN; Bosman FT
J Pathol; 1997 Jul; 182(3):331-8. PubMed ID: 9349237
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-alpha, epidermal growth factor receptor, and MiB-1 expression in Barrett's-associated neoplasia: correlation with prognosis.
Yacoub L; Goldman H; Odze RD
Mod Pathol; 1997 Feb; 10(2):105-12. PubMed ID: 9127315
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer.
Murray GI; Duncan ME; O'Neil P; McKay JA; Melvin WT; Fothergill JE
J Pathol; 1998 Jul; 185(3):256-61. PubMed ID: 9771478
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of nerve growth factor in poorly differentiated and advanced human esophageal cancer.
Zhu ZW; Friess H; Wang L; Di Mola FF; Zimmermann A; Büchler MW
Anticancer Res; 2000; 20(1A):125-32. PubMed ID: 10769644
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters.
Wang M; Pan JY; Song GR; Chen HB; An LJ; Qu SX
Eur J Surg Oncol; 2007 Mar; 33(2):195-201. PubMed ID: 17046193
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer.
Kulke MH; Odze RD; Mueller JD; Wang H; Redston M; Bertagnolli MM
J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1579-86. PubMed ID: 15173710
[TBL] [Abstract][Full Text] [Related]
19. LRIG2 in contrast to LRIG1 predicts poor survival in early-stage squamous cell carcinoma of the uterine cervix.
Hedman H; Lindström AK; Tot T; Stendahl U; Henriksson R; Hellberg D
Acta Oncol; 2010 Aug; 49(6):812-5. PubMed ID: 20553099
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of matrix metalloproteinase 11 in human gastric carcinoma and its clinicopathologic significance.
Zhao ZS; Chu YQ; Ye ZY; Wang YY; Tao HQ
Hum Pathol; 2010 May; 41(5):686-96. PubMed ID: 20060156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
